Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Sep 06, 2022

BUY
$6.85 - $8.87 $1,424 - $1,844
208 New
208 $2,000
Q2 2022

Aug 12, 2022

SELL
$6.85 - $8.87 $1,424 - $1,844
-208 Closed
0 $0
Q3 2021

Oct 06, 2021

BUY
$9.63 - $12.47 $2,003 - $2,593
208 New
208 $3,000

Others Institutions Holding AMYT

About Amryt Pharma plc


  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.